In alignment with Canada's Biomanufacturing and Life Sciences Strategy, the objectives of Canada Biomedical Research Fund (CBRF) and the Biosciences Research Infrastructure Fund (BRIF) are to help ensure that Canada is prepared for future pandemics by increasing domestic capacity through investments and partnerships across the academic, public, private and non-profit sectors to produce life-saving vaccines and therapeutics.
In March 2023, five hubs were awarded through the BRIF Stage 1 competition, including Canada's Immuno-Engineering and Biomanufacturing Hub (CIEBH) located at UBC. The second BRIF competition was also launched as a partnership with the Canada Biomedical Research Fund (CBRF). This competition will award up to $570 million for cutting-edge research, talent development and research infrastructure projects associated with the five biomedical research hubs. The CFI will invest up to $277 million in research infrastructure funding through the CBRF BRIF Stage 2 competition and will fund up to 60 percent of a project’s eligible infrastructure costs. In addition, the CFI will provide up to $83 million for associated operating costs through the Infrastructure Operating Fund.
For program information and detailed instructions on how to complete the full application
CBRF-BRIF Program Information CFI BRIF Detailed instructions